NSC |
Compound |
Enrichment |
Correlation |
NSC 749600 |
Null |
0.000649370174092106 |
0.11157105 |
NSC 750050 |
Null |
0.000649370174092106 |
0.2098988 |
NSC 753456 |
2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole |
0.000649370174092106 |
0.049472717 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.000710545569439728 |
0.1828512 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.000710545569439728 |
0.30288831 |
NSC 359415 |
Null |
0.000710545569439728 |
-0.042647485 |
NSC 601679 |
Null |
0.000710545569439728 |
0.12162377 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.000710545569439728 |
0.32148904 |
NSC 637209 |
Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) |
0.000710545569439728 |
0.26646791 |
NSC 664404 |
- |
0.000710545569439728 |
0.15338176 |